期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 446, 期 1-3, 页码 37-42出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(02)01823-X
关键词
mu-opioid receptor; naltrexone; receptor up-regulation; constitutive internalization; dynamin-2; G-protein receptor kinase-2
资金
- NIDA NIH HHS [DA 12868] Funding Source: Medline
Chronic treatment with opioid receptor antagonists has been shown to increase the density of mu-, delta- and kappa-opioid receptors in cell culture and in the intact animal. Although opioid receptor antagonist-induced up-regulation is a robust phenomenon, the mechanisms responsible for the increase in receptor density remain unclear. In the present study, changes in a kinase and a GTPase that have been implicated in G-protein-coupled receptor regulation were examined following opioid receptor antagonist treatment. Mice were implanted s.c. with a naltrexone pellet or placebo pellet. On the eighth day following implantation, spinal cord was removed and G-protein receptor kinase-2 (GRK-2) and dynamin-2 abundance were determined using a quantitative immunoblot approach. Changes in p-opioid receptor density were also determined. Naltrexone treatment produced a significant (145%) increase in mu-opioid receptor density. Naltrexone treatment was associated with a significant 36% decrease in GRK-2 and 30% decrease in dynamin-2 abundance in spinal cord. These data raise the possibility that opioid receptor antagonist-induced mu-opioid receptor up-regulation in the intact animal may be due to a reduction in constitutive internalization of opioid receptors. (C) 2002 Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据